Sponsored Links

BRIEF-Regeneron Pharma shares resume trading, up 16 percent

NEW YORK | Wed May 1, 2013 11:17am EDT

NEW YORK May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval

likely delayed * Shares up 13.2 percent as shares of Allergan slide after co says

vision drug approval likely delayed

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.